Hanks, B. A., Zhao, F., Evans, K., Holtzhausen, A., Tsutsui, M., & Tyler, D. (2015). Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy. In Journal of Clinical Oncology (Vol. 33, pp. 3054–3054). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.3054

Hanks, Brent Allen, Fei Zhao, Kathy Evans, Alisha Holtzhausen, Masahito Tsutsui, and Douglas Tyler. “Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy.” In Journal of Clinical Oncology, 33:3054–3054. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3054.

Hanks BA, Zhao F, Evans K, Holtzhausen A, Tsutsui M, Tyler D. Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3054–3054.

Hanks, Brent Allen, et al. “Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 3054–3054. Crossref, doi:10.1200/jco.2015.33.15_suppl.3054.

Hanks BA, Zhao F, Evans K, Holtzhausen A, Tsutsui M, Tyler D. Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3054–3054.